학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 915건 | 목록 1~20
Academic Journal
Sztupinszki Z; Danish Cancer Institute, Copenhagen, Denmark. Zsofia.sztupinszki@childrens.harvard.edu.; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Zsofia.sztupinszki@childrens.harvard.edu.; Fiam R; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.; Pipek O; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.; Diossy M; Danish Cancer Institute, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Börcsök J; Danish Cancer Institute, Copenhagen, Denmark.; Prosz A; Danish Cancer Institute, Copenhagen, Denmark.; Csabai I; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.; Szallasi Z; Danish Cancer Institute, Copenhagen, Denmark. Zoltan.szallasi@childrens.harvard.edu.; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Zoltan.szallasi@childrens.harvard.edu.; Department of Bioinformatics, Semmelweis University, Budapest, Hungary. Zoltan.szallasi@childrens.harvard.edu.
Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Academic Journal
Abou Alaiwi S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cardiology, Yale New Haven Hospital, New Haven, CT 06510, USA.; Adib E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.; Spisak S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Institute of Molecular Life Sciences, Center of Excellence of The Hungarian Academy of Sciences, HUN-REN Research Centre for Natural Sciences, 1117 Budapest, Hungary; HUN-REN-ONKOL-TTK-HCEMM Oncogenomics Research Group, Budapest, Hungary.; Prosz A; Translational Cancer Genomics Group, Danish Cancer Institute, Copenhagen, Denmark.; Cordeiro P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA.; El Zarif T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Medicine, Yale New Haven Hospital, New Haven, CT 06510, USA.; Sztupinszki ZM; Translational Cancer Genomics Group, Danish Cancer Institute, Copenhagen, Denmark; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Nassar AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Hematology/Oncology, Yale New Haven Hospital, New Haven, CT 06510, USA.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Campbell R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Steinharter JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.; Machiela M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Rockville, MD 20850, USA.; Dutta D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Rockville, MD 20850, USA.; Chanock S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Rockville, MD 20850, USA.; Purdue M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Rockville, MD 20850, USA.; Pomerantz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Szallasi Z; Translational Cancer Genomics Group, Danish Cancer Institute, Copenhagen, Denmark; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA. Electronic address: sylvan_baca@dfci.harvard.edu.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: toni_choueiri@dfci.harvard.edu.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA. Electronic address: matthew_freedman@dfci.harvard.edu.
Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Academic Journal
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Kilim O; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Pipek O; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.; Sztupinszki Z; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Danish Cancer Institute, Copenhagen, Denmark.; Diossy M; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Prosz A; Danish Cancer Institute, Copenhagen, Denmark.; Naceur-Lombardelli C; Cancer Research Institute, University College London Cancer Institute, London, UK.; Veeriah S; Cancer Research Institute, University College London Cancer Institute, London, UK.; Moore D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals NHS Foundation Trust, London, UK.; Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, London, UK.; Fillinger J; Department of Pathology, National Koranyi Institute of Pulmonology, Budapest, Hungary.; Moldvay J; 1 Department of Pulmonology, National Koranyi Institute of Pulmonology, Budapest, Hungary.; Pulmonology Clinic, University of Szeged, Albert Szent-Gyorgyi Medical School, Szeged, Hungary.; Translational Oncopulmonology Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.; Csabai I; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.; Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Szallasi Z; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Danish Cancer Institute, Copenhagen, Denmark.; 1 Department of Pulmonology, National Koranyi Institute of Pulmonology, Budapest, Hungary.; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; Translational Oncopulmonology Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Academic Journal
Lózsa R; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.; Szikriszt B; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.; Németh E; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.; Szeltner Z; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.; Martinek R; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.; Doctoral School of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.; Póti Á; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.; Feik T; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.; Kollarics S; Institute for Solid State Physics and Optics, HUN-REN Wigner Research Centre for Physics, Budapest, Hungary.; Department of Physics, Institute of Physics, Budapest University of Technology and Economics, Budapest, Hungary.; Márkus BG; Institute for Solid State Physics and Optics, HUN-REN Wigner Research Centre for Physics, Budapest, Hungary.; Stavropoulos Center for Complex Quantum Matter, Department of Physics and Astronomy, University of Notre Dame, Notre Dame, IN, USA.; Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Sztupinszki Z; Danish Cancer Institute, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Simon F; Department of Physics, Institute of Physics, Budapest University of Technology and Economics, Budapest, Hungary.; Stavropoulos Center for Complex Quantum Matter, Department of Physics and Astronomy, University of Notre Dame, Notre Dame, IN, USA.; Shibata T; Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; Szallasi Z; Danish Cancer Institute, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; Richardson AL; Johns Hopkins University School of Medicine, Baltimore, MD, USA. aricha58@jhu.edu.; Szüts D; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary. szuts.david@ttk.hu.; National Laboratory for Drug Research and Development, Budapest, Hungary. szuts.david@ttk.hu.
Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE
Academic Journal
Vergote, I.Ausems, M.Brasiuniene, B.Brenton, J.Büttner, R.Colombo, N.González-Martín, A.Harter, P.Lambrechts, D.Lorusso, D.Madry, R.Mirza, M.R.Pujol, P.Ray-Coquard, I.Abreu, M.Balboni, S.Banerjee, S.Barberis, M.Barretina Ginesta, M.P.Baurain, J.-F.Bignami, M.Bjorge, L.Blecharz, P.Bruchim, I.Capilna, M.Cerana, N.Cicchetti, A.Collins, D.Concin, N.D’Incalci, M.Davidson, B.de la Motte Rouge, T.De Iaco, P.Demirkiran, F.Denys, H.Doerk, T.Dorum, A.Ferrero, A.Fidalgo, A.P.Genuardi, M.Gladieff, L.Glasspool, R.Grimm, C.Gultekin, M.Hahnen, E.Hasenburg, A.Hegmane, A.Heinzelmann, V.Hogdall, E.Janavicius, R.Jarmalaite, S.Kalachand, R.Kaneva, R.Kilickap, S.Kocian, R.Kolencik, D.Kristeleit, R.Kryzhanivska, A.Leary, A.Lemley, B.Ligtenberg, M.López-Guerrero, J.A.Lord, C.J.Avall-Lundqvist, E.Maenpaa, J.Mahner, S.Marmé, F.Marth, C.McNeish, I.Merkelbach-Bruse, S.Mourits, M.Normanno, N.Oaknin, A.Ojamaa, K.Papdimitriou, C.Penault-Llorca, F.Perrone, A.M.Pignata, S.Pikarsky, E.Rouleau, E.Rubio, M.Sapino, A.Schmalfeldt, B.Sehouli, J.Shapira, R.Steffensen, K.D.Sukhin, V.Syrios, J.Szallasi, Z.Taskiran, C.Terzic, M.Tischkowitz, M.Toth, I.Van de Vijver, K.Vardar, M.A.Wasag, B.Wimberger, P.Witteveen, E.Brenton, J.D.Ausems, M.G.E.M.
In Annals of Oncology March 2022 33(3):276-287
Academic Journal
Sharad S; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD 20817, USA.; Henry Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Dr, Suite 100, Bethesda, MD 20817, USA.; Sztupinszki ZM; Danish Cancer Society Research Center, 2100 Copenhagen, Denmark.; Chen Y; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; Henry Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Dr, Suite 100, Bethesda, MD 20817, USA.; Kuo C; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; Henry Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Dr, Suite 100, Bethesda, MD 20817, USA.; Ravindranath L; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; Henry Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Dr, Suite 100, Bethesda, MD 20817, USA.; Szallasi Z; Danish Cancer Society Research Center, 2100 Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.; SE-NAP Brain Metastasis Research Group, 2nd Department of Pathology, Semmelweis University, 1085 Budapest, Hungary.; Petrovics G; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD 20817, USA.; Henry Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Dr, Suite 100, Bethesda, MD 20817, USA.; Sreenath TL; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; Henry Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Dr, Suite 100, Bethesda, MD 20817, USA.; Dobi A; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD 20817, USA.; Henry Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Dr, Suite 100, Bethesda, MD 20817, USA.; Rosner IL; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD 20817, USA.; Department of Urology, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA.; Srinivasan A; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; Henry Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Dr, Suite 100, Bethesda, MD 20817, USA.; Srivastava S; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; Cullen J; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD 20817, USA.; Henry Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Dr, Suite 100, Bethesda, MD 20817, USA.; Li H; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 6720A Rockledge Drive, Suite 300, Bethesda, MD 20817, USA.; Henry Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Dr, Suite 100, Bethesda, MD 20817, USA.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
P Shanmugam S; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Zhou Y; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Stelter I; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hanlon T; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Temple University School of Medicine, Philadelphia, PA, USA.; Bekele RT; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Bellmunt J; Harvard Medical School, Boston, MA, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Szallasi Z; Danish Cancer Institute, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; Mouw KW; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Brigham & Women's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Publisher: Sage Publications Country of Publication: United States NLM ID: 101668567 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-3735 (Electronic) Linking ISSN: 23523727 NLM ISO Abbreviation: Bladder Cancer Subsets: PubMed not MEDLINE
Li Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Zou L; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA.; Li Q; Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark.; Haibe-Kains B; Medical Oncology Department, Jules Bordet Institute, Brussels, Belgium.; Machine Learning Group, Université Libre de Bruxelles, Brussels, Belgium.; Tian R; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Li Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Desmedt C; Medical Oncology Department, Jules Bordet Institute, Brussels, Belgium.; Sotiriou C; Medical Oncology Department, Jules Bordet Institute, Brussels, Belgium.; Szallasi Z; Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark.; Children's Hospital Informatics Program at the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts, USA.; Iglehart JD; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Richardson AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. arichardson@partners.org.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. arichardson@partners.org.; Wang ZC; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. zhigang_wang@dfci.harvard.edu.; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. zhigang_wang@dfci.harvard.edu.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; In Process
Academic Journal
TRACERx Consortium 2019, ' A clonal expression biomarker associates with lung cancer mortality ', Nature Medicine, vol. 25, no. 10, pp. 1540-1548 . https://doi.org/10.1038/s41591-019-0595-z
Biswas, D, Birkbak, N J, Rosenthal, R, Hiley, C T, Lim, E L, Papp, K, Boeing, S, Krzystanek, M, Djureinovic, D, La Fleur, L, Greco, M, Döme, B, Fillinger, J, Brunnström, H, Wu, Y, Moore, D A, Skrzypski, M, Abbosh, C, Litchfield, K, Al Bakir, M, Watkins, T B K, Veeriah, S, Wilson, G A, Jamal-Hanjani, M, Moldvay, J, Botling, J, Chinnaiyan, A M, Micke, P, Hackshaw, A, Bartek, J, Csabai, I, Szallasi, Z, Herrero, J, McGranahan, N, Swanton, C & TRACERx Consortium 2019, 'A clonal expression biomarker associates with lung cancer mortality', Nature Medicine, vol. 25, no. 10, pp. 1540-1548. https://doi.org/10.1038/s41591-019-0595-z
Academic Journal
Diossy M; Danish Cancer Institute, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Tisza V; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Li H; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Sahgal P; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Zhou J; Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Sztupinszki Z; Danish Cancer Institute, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Young D; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Nousome D; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Kuo C; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Jiang J; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Chen Y; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Ebner R; CytoTest Inc., Rockville, MD, USA.; Sesterhenn IA; Joint Pathology Center, Silver Spring, MD, USA.; Moncur JT; Joint Pathology Center, Silver Spring, MD, USA.; Chesnut GT; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; Petrovics G; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Klus GT; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Valcz G; MTA-SE Molecular Medicine Research Group, Hungarian Academy of Sciences, Budapest, 1051, Hungary.; Nuzzo PV; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Ribli D; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.; Börcsök J; Danish Cancer Institute, Copenhagen, Denmark.; Prosz A; Danish Cancer Institute, Copenhagen, Denmark.; Krzystanek M; Danish Cancer Institute, Copenhagen, Denmark.; Ried T; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Szuts D; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.; Rizwan K; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.; Kaochar S; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.; Pathania S; Center for Personalized Cancer Therapy, University of Massachusetts, Boston, MA, USA.; Department of Biology, University of Massachusetts, Boston, MA, USA.; D'Andrea AD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Csabai I; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.; Srivastava S; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; Department of Biochemistry and Molecular & Cell Biology, Georgetown University School of Medicine, Washington, DC, USA.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. freedman@broadinstitute.org.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. freedman@broadinstitute.org.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. freedman@broadinstitute.org.; Dobi A; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. adobi@cpdr.org.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA. adobi@cpdr.org.; Spisak S; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary. Spisak.sandor@ttk.hu.; Szallasi Z; Danish Cancer Institute, Copenhagen, Denmark. Zoltan.Szallasi@childrens.harvard.edu.; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Zoltan.Szallasi@childrens.harvard.edu.; 2nd Department of Pathology and Department of Bioinformatics, Semmelweis University, Budapest, Hungary. Zoltan.Szallasi@childrens.harvard.edu.
Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Academic Journal
Biswas D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. dhruva.biswas@crick.ac.uk.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK. dhruva.biswas@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. dhruva.biswas@crick.ac.uk.; Liu YH; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Herrero J; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.; Wu Y; Centre for Inflammation Biology and Cancer Immunology, King's College London, London, UK.; Department of Medical Oncology, Guy's Hospital, London, UK.; Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK.; Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Metastasis Lab, University College London Cancer Institute, London, UK.; Department of Thoracic Surgery, Respiratory Center, Toranomon Hospital, Tokyo, Japan.; Grigoriadis K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Lu WT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Magno N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Ward S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Genomics Science Technology Platform, The Francis Crick Institute, London, UK.; Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; de Carné Trécesson S; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.; East P; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.; Malhi A; Cancer Research UK and University College London Cancer Trials Centre, University College London, London, UK.; Snell DM; Genomics Science Technology Platform, The Francis Crick Institute, London, UK.; O'Neill O; Genomics Science Technology Platform, The Francis Crick Institute, London, UK.; Leonce D; Genomics Science Technology Platform, The Francis Crick Institute, London, UK.; Mattsson J; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Lindberg A; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Micke P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Moldvay J; 1st Department of Pulmonology, National Koranyi Institute of Pulmonology, Budapest, Hungary.; Department of Pulmonology, University of Szeged Albert Szent-Gyorgyi Medical School, Szeged, Hungary.; Megyesfalvi Z; National Koranyi Institute of Pulmonology, Budapest, Hungary.; Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary.; Department of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Dome B; National Koranyi Institute of Pulmonology, Budapest, Hungary.; Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary.; Department of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Translational Medicine, Lund University, Lund, Sweden.; Fillinger J; National Koranyi Institute of Pulmonology, Budapest, Hungary.; Nicod J; Genomics Science Technology Platform, The Francis Crick Institute, London, UK.; Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.; Szallasi Z; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Hackshaw A; Cancer Research UK and University College London Cancer Trials Centre, University College London, London, UK.; Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Lab, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK.; Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nbirkbak@clin.au.dk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. nbirkbak@clin.au.dk.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. nbirkbak@clin.au.dk.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. nbirkbak@clin.au.dk.; Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Charles.Swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. Charles.Swanton@crick.ac.uk.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Szallasi, Z.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어